Investor Presentaiton slide image

Investor Presentaiton

Polo-like kinase-1 identified as a therapeutic target in RDEB CSCC Psoriasis vs NLS Fold Change 19 Oncogene. 2011 30(46):4666-77. PMID: 21602893 PMCID: PMC3219832 Fold change comparison SCC vs normal skin with psoriasis lesional vs non-lesional skin 0 10 T 10 SCC vs NS Fold Change • SCC / Psors in Common • SCC specific 100 0 ONCONOVA THERAPEUTICS
View entire presentation